Postoperative Analgesic Effects of Intravenous Dexamethasone for Patients Undergoing Cesarean Delivery under Spinal Anesthesia at Dilla University Referral Hospital, Ethiopia, 2021: A randomized Controlled Trial.

Postoperative Analgesic Effects of Intravenous Dexamethasone for Patients Undergoing Cesarean Delivery under Spinal Anesthesia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202310828674007

Enrollment

112

Registered

2023-10-12

Start date

2022-01-10

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Anaesthesia

Interventions

Normal saline

Dexamethasone

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All ASA II parturient mothers who underwent elective caesarean delivery under spinal anesthesia.

Exclusion criteria

Exclusion criteria: - Diabetes mellitus, heart failure. - Patient with preeclampsia, eclampsia - Patients unable to self-report acute pain - Cognitive impairment (Dementia, Alzheimer's). - Acute/chronic pain diagnosis

Design outcomes

Primary

Measure	Time frame
-Time to first analgesic request, Total analgesic consumption in 24hr, postoperative pain score	—

Secondary

Measure	Time frame
respiratory rate, SPO2 and PONV	—

Countries

Ethiopia

Contacts

Public ContactHailemariam Mulugeta

second Author

hmerry1990@gmail.com+251970415208

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026